Studying tissue and blood samples to learn about soft tissue sarcoma
Studies tissue and blood samples from people with soft tissue sarcoma to learn more.
Key facts
- Who runs it
- Memorial Sloan Kettering Cancer Center
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, and Rockville Centre, United StatesSee the 7 sites
- Trial code
- Registry title
- Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- Jun 2002
- Expected to end
- Jun 2027
- Type of study
- Observational
- Treatments tested
- Specimen protocol
- Record updated
- 30 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with known or suspected sarcoma who have had or will have tissue removed for treatment or diagnosis. Leftover tissue and blood samples are used for lab studies.
- Sex
- All sexes can join.
- Disease stage
- Known or suspected sarcoma.
- Earlier treatment
- Earlier hormonal therapy, chemotherapy, radiation, immunotherapy or surgery is allowed.
Main reasons for not taking part
- The record lists no exclusion criteria.
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- All patients with known or suspected sarcoma who will have or have had tissue removed for therapeutic or diagnostic purposes
- Patients will be entered without preference for any particular racial/ethnic group or gender
- Patients may have received prior hormonal therapy, cytotoxic chemotherapy, irradiation, immunotherapy or surgical therapy
- Tissue specimens must be large enough in quantity to allow routine pathologic analysis, with the research laboratory specimen removed from the residual specimen, which would otherwise be discarded. Optimal tissue amounts for snap freeze: Core biopsy - 2 tissue cores Incisional biopsy- 0.5 to 1.5 grams Resected sarcoma specimen- 1.0 to 50 grams depending on size of specimen Normal fat or muscle tissue - 0.5 to 4.0 grams (if available from resected sarcoma specimen) Optimal tissue amounts for RNA later Core biopsy - 2 tissue cores Incisional biopsy- 30 mg (three 3 x 3 x 3 mm cubes) Resected sarcoma specimen - 30 mg (three 3 x 3 x 3 mm cubes) Normal fat or muscle tissue - 30 mg (three 3 x 3 x 3 mm cube
Who cannot take part
- None
Where in United States
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)Basking Ridge, United StatesContact: Samuel Singer, MDTaking people
- Memorial Sloan Kettering Commack (Consent and Follow-Up)Commack, United StatesContact: Samuel Singer, MDTaking people
- Memorial Sloan Kettering Westchester (Consent and Followup)Harrison, United StatesContact: Samuel Singer, MDTaking people
- Memorial Sloan Kettering Monmouth (Consent and Followup)Middletown, United StatesContact: Samuel Singer, MDTaking people
- Memorial Sloan Kettering Bergen (Consent and Follow-Up)Montvale, United StatesContact: Sam Singer, MDTaking people
- Memorial Sloan Kettering Cancer Center (All Protocol Activities)New York, United StatesContact: Samuel Singer, M.D.Taking people
- Memorial Sloan Kettering Nassau (Consent and Followup)Rockville Centre, United StatesContact: Sam Singer, MDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.
The group in the trial
- 1
Sarcoma patients undergoing core biopsy, incisional biopsy or definitive surgical resection for soft tissue masses of extremity, trunk or retroperitoneum
Treatment: Specimen protocol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- Plain-language title
- Studying tissue and blood samples to learn about soft tissue sarcomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 30 July 2026